Bristol Myers Squibb (BMY) Liabilities and Shareholders Equity (2009 - 2026)
Bristol Myers Squibb's Liabilities and Shareholders Equity came in at $87.63 billion for Q2 2026, down 7.4% from $94.68 billion a year earlier but up 1.3% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb's Liabilities and Shareholders Equity was $90.04 billion, down 2.8% from FY2024.
- Liabilities and Shareholders Equity has declined in each of the last six years, with a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $92.6 billion in FY2024 (-2.7%), $95.16 billion in FY2023 (-1.7%), $96.82 billion in FY2022 (-11.4%) and $109.31 billion in FY2021 (-7.7%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $86.48 billion (Q1 2026) to $110.89 billion (Q3 2021).
- Year-over-year, Liabilities and Shareholders Equity has declined for three consecutive quarters, with an average decline of 2.5% over the last eight quarters.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2024 (growth of 5.0%), and the weakest in Q3 2021 (a decline of 11.7%).
- Business Quant data shows BMY's Liabilities and Shareholders Equity at $86.48 billion (Q1 2026), $90.04 billion (Q4 2025) and $96.89 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,159.63 Bn | 1,128.22 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 625.08 Bn | 543.61 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 511.88 Bn | 484.99 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.24 Bn | 320.62 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.39 Bn | 261.38 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.27 Bn | 234.95 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 234.87 Bn | 190.27 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.00 Bn | 168.19 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Bristol Myers Squibb | 125.35 Bn | 76.62 Bn | 9.25 Bn | 87.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87.63 Bn |
| Mar 31, 2026 | 86.48 Bn |
| Dec 31, 2025 | 90.04 Bn |
| Sep 30, 2025 | 96.89 Bn |
| Jun 30, 2025 | 94.68 Bn |
| Mar 31, 2025 | 92.43 Bn |
| Dec 31, 2024 | 92.60 Bn |
| Sep 30, 2024 | 93.67 Bn |
| Jun 30, 2024 | 94.65 Bn |
| Mar 31, 2024 | 99.03 Bn |
| Dec 31, 2023 | 95.16 Bn |
| Sep 30, 2023 | 91.26 Bn |
| Jun 30, 2023 | 93.49 Bn |
| Mar 31, 2023 | 94.28 Bn |
| Dec 31, 2022 | 96.82 Bn |
| Sep 30, 2022 | 98.20 Bn |
| Jun 30, 2022 | 100.36 Bn |
| Mar 31, 2022 | 103.03 Bn |
| Dec 31, 2021 | 109.31 Bn |
| Sep 30, 2021 | 110.89 Bn |
API Access
Bristol Myers Squibb Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();